Spots Global Cancer Trial Database for emesis
Every month we try and update this database with for emesis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Dexamethasone Reduces Postoperative Emesis by Decreasing PGF2α and LTC4 Levels | NCT01811199 | Thyroid Cancer Breast Cancer | 18 Years - 65 Years | Marmara University | ||
| Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy | NCT00152867 | Cancer Emesis Nausea | Dexamethasone | 18 Years - | University Health Network, Toronto | |
| Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy | NCT01046240 | Emesis | Palonosetron | 18 Years - | Clinica Universidad de Navarra, Universidad de Navarra | |
| Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy | NCT00169572 | Nausea and Vomi... Chemotherapy-In... | Aprepitant Ondansetron GW679769 Dexamethasone | 18 Years - | GlaxoSmithKline | |
| Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide | NCT02991456 | Chemo-radiation... | Rolapitant Ondansetron | 18 Years - | Duke University | |
| DAnish Nausea Study In Advanced Cancer-Epidemiology: A Danish Multicenter Trial to Investigate the Prevalence and Treatment of Nausea and/or Vomiting in Patients With Advanced Cancer. | NCT02980289 | Advanced Cancer Nausea Emesis | 18 Years - | Odense University Hospital | ||
| Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy | NCT01046240 | Emesis | Palonosetron | 18 Years - | Clinica Universidad de Navarra, Universidad de Navarra | |
| Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation | NCT01788605 | Hematologic Mal... | ramosetron | 18 Years - | The Catholic University of Korea | |
| DAnish Nausea Study In Advanced Cancer-Epidemiology: A Danish Multicenter Trial to Investigate the Prevalence and Treatment of Nausea and/or Vomiting in Patients With Advanced Cancer. | NCT02980289 | Advanced Cancer Nausea Emesis | 18 Years - | Odense University Hospital | ||
| Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy | NCT00169572 | Nausea and Vomi... Chemotherapy-In... | Aprepitant Ondansetron GW679769 Dexamethasone | 18 Years - | GlaxoSmithKline | |
| Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy | NCT02407600 | Non-small Cell ... Vomiting Nausea Emesis | FOSAPREPITANT (... Placebo | 18 Years - | State University of New York - Upstate Medical University | |
| Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer Patients | NCT00869973 | Emesis | Aprepitant dexamethasone | 18 Years - | S. Maria Hospital, Terni | |
| Chemoradiation-Induced Nausea and Emesis: Quality of Life | NCT00394602 | Gastric Cancer Pancreatic Canc... Cervical Cancer Vulvar Cancer Endometrial Can... Anal Cancer | Interview Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients? Formal Study | NCT00550251 | Nausea Vomiting | Acupressure Wri... Placebo wristba... | 18 Years - | Sue Ryder Care | |
| Randomized Crossover Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Granisetron in Cancer Patients | NCT00450853 | Vomiting | granisetron | 18 Years - | Clinica Universidad de Navarra, Universidad de Navarra | |
| Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting | NCT01432015 | Ovarian Cancer Uterine Cancer | fosaprepitant aprepitant Oral Placebo IV placebo | 18 Years - | Gynecologic Oncology Associates | |
| Dexamethasone Reduces Postoperative Emesis by Decreasing PGF2α and LTC4 Levels | NCT01811199 | Thyroid Cancer Breast Cancer | 18 Years - 65 Years | Marmara University | ||
| Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy | NCT00152867 | Cancer Emesis Nausea | Dexamethasone | 18 Years - | University Health Network, Toronto | |
| Ondansetron Versus Aprepitant Plus Ondansetron for Emesis | NCT00954941 | Hematologic Dis... Acute Myelogeno... Myelodysplastic... Chronic Myeloge... | Ondansetron Aprepitant | 18 Years - | M.D. Anderson Cancer Center | |
| Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy | NCT01046240 | Emesis | Palonosetron | 18 Years - | Clinica Universidad de Navarra, Universidad de Navarra |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
